Hyperbaric Oxygen Therapy > Parkinson's Disease >

Hyperbaric oxygen therapy increases norepinephrine levels for the treatment of Parkinson’s Disease

Tissue concentrations of norepinephrine (NE) are markedly decreased in various regions of the brain in Parkinson patients. Not only is NE involved in cognitive operations, "freezing" of gait, tremor, ... Read More

Parkinson progression reduced by mild hyperbaric oxygen therapy

Mild or lower pressure hyperbaric oxygen therapy (aka m-HBOT) was able to demonstrate a marked reduction in Parkinson’s Disease (PD) symptoms in just 11 weeks! PD is a common progressive neurodeg... Read More